A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma

NCT04257461 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Small Bowel Adenocarcinoma

Interventions

DRUG: Fluoropyrimidine
DRUG: Oxaliplatin

Sponsor

Belgian Group of Digestive Oncology

Collaborators

[object Object]
[object Object]